Zobrazeno 1 - 10 of 303 pro vyhledávání: '"Aguilar-Gurrieri C"'
1
Akademický článek
Production and Immunogenicity of FeLV Gag-Based VLPs Exposing a Stabilized FeLV Envelope Glycoprotein.
Autor: Ortiz R; IrsiCaixa, 08916 Badalona, Spain.; Doctorate School, Microbiology Department, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain., Barajas A; IrsiCaixa, 08916 Badalona, Spain.; Centre for Health and Social Care Research (CESS), Faculty of Medicine, University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic, Spain., Pons-Grífols A; IrsiCaixa, 08916 Badalona, Spain.; Doctorate School, Microbiology Department, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain., Trinité B; IrsiCaixa, 08916 Badalona, Spain., Tarrés-Freixas F; IrsiCaixa, 08916 Badalona, Spain., Rovirosa C; IrsiCaixa, 08916 Badalona, Spain., Urrea V; IrsiCaixa, 08916 Badalona, Spain., Barreiro A; HIPRA, 17170 Amer, Spain., Gonzalez-Tendero A; HIPRA, 17170 Amer, Spain., Rovira-Rigau M; HIPRA, 17170 Amer, Spain., Cardona M; HIPRA, 17170 Amer, Spain., Ferrer L; HIPRA, 17170 Amer, Spain., Clotet B; IrsiCaixa, 08916 Badalona, Spain.; Centre for Health and Social Care Research (CESS), Faculty of Medicine, University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic, Spain.; Infectious Diseases Department, Germans Trias I Pujol Hospital, 08916 Badalona, Spain., Carrillo J; IrsiCaixa, 08916 Badalona, Spain., Aguilar-Gurrieri C; IrsiCaixa, 08916 Badalona, Spain., Blanco J; IrsiCaixa, 08916 Badalona, Spain.; Centre for Health and Social Care Research (CESS), Faculty of Medicine, University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic, Spain.; Germans Trias I Pujol Research Institute (IGTP), 08916 Badalona, Spain.; CIBERINFEC, ISCIII, 28029 Madrid, Spain.
Publikováno v: Viruses [Viruses] 2024 Jun 19; Vol. 16 (6). Date of Electronic Publication: 2024 Jun 19.
Zobrazit plný text záznamu
2
Akademický článek
VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice.
Autor: Trinité B; IrsiCaixa, Badalona, Spain. Electronic address: btrinite@irsicaixa.es., Durr E; Merck & Co., Inc., Rahway, NJ, USA., Pons-Grífols A; IrsiCaixa, Badalona, Spain., O'Donnell G; Merck & Co., Inc., Rahway, NJ, USA., Aguilar-Gurrieri C; IrsiCaixa, Badalona, Spain., Rodriguez S; Merck & Co., Inc., Rahway, NJ, USA., Urrea V; IrsiCaixa, Badalona, Spain., Tarrés F; IrsiCaixa, Badalona, Spain., Mane J; Merck & Co., Inc., Rahway, NJ, USA., Ortiz R; IrsiCaixa, Badalona, Spain., Rovirosa C; IrsiCaixa, Badalona, Spain., Carrillo J; IrsiCaixa, Badalona, Spain., Clotet B; IrsiCaixa, Badalona, Spain; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain., Zhang L; Merck & Co., Inc., Rahway, NJ, USA. Electronic address: lan_zhang2@merck.com., Blanco J; IrsiCaixa, Badalona, Spain; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain; Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain; CIBERINFEC, Madrid, Spain. Electronic address: jblanco@irsicaixa.es.
Publikováno v: Vaccine [Vaccine] 2024 May 31; Vol. 42 (15), pp. 3474-3485. Date of Electronic Publication: 2024 Apr 18.
Zobrazit plný text záznamu
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant.
Autor: Ávila-Nieto C; IrsiCaixa AIDS Research Institute, Badalona, Spain., Vergara-Alert J; Unitat Mixta d'Investigació IRTA-UAB en Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; IRTA Programa de Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Amengual-Rigo P; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Spain., Ainsua-Enrich E; IrsiCaixa AIDS Research Institute, Badalona, Spain., Brustolin M; Unitat Mixta d'Investigació IRTA-UAB en Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; IRTA Programa de Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Rodríguez de la Concepción ML; IrsiCaixa AIDS Research Institute, Badalona, Spain., Pedreño-Lopez N; IrsiCaixa AIDS Research Institute, Badalona, Spain., Rodon J; Unitat Mixta d'Investigació IRTA-UAB en Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; IRTA Programa de Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Urrea V; IrsiCaixa AIDS Research Institute, Badalona, Spain., Pradenas E; IrsiCaixa AIDS Research Institute, Badalona, Spain., Marfil S; IrsiCaixa AIDS Research Institute, Badalona, Spain., Ballana E; IrsiCaixa AIDS Research Institute, Badalona, Spain.; Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.; Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Infecciosas, Instituto de Salud Carlos III (ISCIII), Madrid, Spain., Riveira-Muñoz E; IrsiCaixa AIDS Research Institute, Badalona, Spain., Pérez M; Unitat Mixta d'Investigació IRTA-UAB en Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; IRTA Programa de Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Roca N; Unitat Mixta d'Investigació IRTA-UAB en Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; IRTA Programa de Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Tarrés-Freixas F; IrsiCaixa AIDS Research Institute, Badalona, Spain., Carabelli J; IrsiCaixa AIDS Research Institute, Badalona, Spain., Cantero G; Unitat Mixta d'Investigació IRTA-UAB en Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; IRTA Programa de Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Pons-Grífols A; IrsiCaixa AIDS Research Institute, Badalona, Spain., Rovirosa C; IrsiCaixa AIDS Research Institute, Badalona, Spain., Aguilar-Gurrieri C; IrsiCaixa AIDS Research Institute, Badalona, Spain., Ortiz R; IrsiCaixa AIDS Research Institute, Badalona, Spain., Barajas A; IrsiCaixa AIDS Research Institute, Badalona, Spain., Trinité B; IrsiCaixa AIDS Research Institute, Badalona, Spain., Lepore R; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Spain., Muñoz-Basagoiti J; IrsiCaixa AIDS Research Institute, Badalona, Spain., Perez-Zsolt D; IrsiCaixa AIDS Research Institute, Badalona, Spain., Izquierdo-Useros N; IrsiCaixa AIDS Research Institute, Badalona, Spain.; Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.; Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Infecciosas, Instituto de Salud Carlos III (ISCIII), Madrid, Spain., Valencia A; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Spain.; Catalan Institution for Research and Advanced Studies, Barcelona, Spain., Blanco J; IrsiCaixa AIDS Research Institute, Badalona, Spain.; Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.; Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Infecciosas, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Centre for Health and Social Care Research (CESS), Faculty of Medicine, University of Vic - Central University of Catalonia (UVic - UCC), Vic, Spain., Clotet B; IrsiCaixa AIDS Research Institute, Badalona, Spain.; Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.; Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Infecciosas, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Centre for Health and Social Care Research (CESS), Faculty of Medicine, University of Vic - Central University of Catalonia (UVic - UCC), Vic, Spain.; Fundació Lluita contra les Infeccions, Hospital Germans Trias i Pujol, Badalona, Spain., Guallar V; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Spain.; Catalan Institution for Research and Advanced Studies, Barcelona, Spain., Segalés J; Unitat Mixta d'Investigació IRTA-UAB en Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; Departament de Sanitat i Anatomia Animals, Facultat de Veterinària, UAB, Cerdanyola del Vallès, Spain., Carrillo J; IrsiCaixa AIDS Research Institute, Badalona, Spain.; Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.; Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Infecciosas, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Publikováno v: Frontiers in immunology [Front Immunol] 2023 Dec 04; Vol. 14, pp. 1291972. Date of Electronic Publication: 2023 Dec 04 (Print Publication: 2023).
Zobrazit plný text záznamu
6
Akademický článek
Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines.
Autor: Aguilar-Gurrieri C; IrsiCaixa AIDS Research Institute, Germans Trias I Pujol Research Institute (IGTP), Badalona, Spain. caguilar@irsicaixa.es., Barajas A; IrsiCaixa AIDS Research Institute, Germans Trias I Pujol Research Institute (IGTP), Badalona, Spain.; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain., Rovirosa C; IrsiCaixa AIDS Research Institute, Germans Trias I Pujol Research Institute (IGTP), Badalona, Spain., Ortiz R; IrsiCaixa AIDS Research Institute, Germans Trias I Pujol Research Institute (IGTP), Badalona, Spain., Urrea V; IrsiCaixa AIDS Research Institute, Germans Trias I Pujol Research Institute (IGTP), Badalona, Spain., de la Iglesia N; IrsiCaixa AIDS Research Institute, Germans Trias I Pujol Research Institute (IGTP), Badalona, Spain., Clotet B; IrsiCaixa AIDS Research Institute, Germans Trias I Pujol Research Institute (IGTP), Badalona, Spain.; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain.; Infectious Diseases Department, Germans Trias I Pujol Hospital, Badalona, Spain.; CIBER de Enfermedades Infecciosas, Madrid, Spain., Blanco J; IrsiCaixa AIDS Research Institute, Germans Trias I Pujol Research Institute (IGTP), Badalona, Spain.; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain.; CIBER de Enfermedades Infecciosas, Madrid, Spain., Carrillo J; IrsiCaixa AIDS Research Institute, Germans Trias I Pujol Research Institute (IGTP), Badalona, Spain. jcarrillo@irsicaixa.es.; CIBER de Enfermedades Infecciosas, Madrid, Spain. jcarrillo@irsicaixa.es.
Publikováno v: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2023 Jul; Vol. 72 (7), pp. 2113-2125. Date of Electronic Publication: 2023 Feb 23.
Zobrazit plný text záznamu
7
Akademický článek
Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform-Analysis of Production and Immunogenicity.
Autor: Ortiz R; AIDS Research Institute, IrsiCaixa, Campus Can Ruti, 08916 Badalona, Spain.; Doctorate School, Microbiology Department, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain., Barajas A; AIDS Research Institute, IrsiCaixa, Campus Can Ruti, 08916 Badalona, Spain.; Doctorate School, Medicine Department, University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic, Spain., Pons-Grífols A; AIDS Research Institute, IrsiCaixa, Campus Can Ruti, 08916 Badalona, Spain.; Doctorate School, Microbiology Department, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain., Trinité B; AIDS Research Institute, IrsiCaixa, Campus Can Ruti, 08916 Badalona, Spain., Tarrés-Freixas F; AIDS Research Institute, IrsiCaixa, Campus Can Ruti, 08916 Badalona, Spain., Rovirosa C; AIDS Research Institute, IrsiCaixa, Campus Can Ruti, 08916 Badalona, Spain., Urrea V; AIDS Research Institute, IrsiCaixa, Campus Can Ruti, 08916 Badalona, Spain., Barreiro A; HIPRA, 17170 Amer, Spain., Gonzalez-Tendero A; HIPRA, 17170 Amer, Spain., Cardona M; HIPRA, 17170 Amer, Spain., Ferrer L; HIPRA, 17170 Amer, Spain., Clotet B; AIDS Research Institute, IrsiCaixa, Campus Can Ruti, 08916 Badalona, Spain.; Doctorate School, Medicine Department, University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic, Spain.; Infectious Diseases Department, Germans Trias I Pujol Hospital, 08916 Badalona, Spain., Carrillo J; AIDS Research Institute, IrsiCaixa, Campus Can Ruti, 08916 Badalona, Spain.; CIBERINFEC, ISCIII, 28029 Madrid, Spain., Aguilar-Gurrieri C; AIDS Research Institute, IrsiCaixa, Campus Can Ruti, 08916 Badalona, Spain., Blanco J; AIDS Research Institute, IrsiCaixa, Campus Can Ruti, 08916 Badalona, Spain.; Doctorate School, Microbiology Department, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.; Doctorate School, Medicine Department, University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic, Spain.; CIBERINFEC, ISCIII, 28029 Madrid, Spain.; Germans Trias I Pujol Research Institute (IGTP), Campus Can Ruti, 08916 Badalona, Spain.
Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2023 May 19; Vol. 24 (10). Date of Electronic Publication: 2023 May 19.
Zobrazit plný text záznamu
8
Akademický článek
Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization.
Autor: Pradenas E; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain., Marfil S; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain., Urrea V; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain., Trigueros M; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain., Pidkova T; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain., Pons-Grífols A; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain., Ortiz R; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain., Rovirosa C; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain., Tarrés-Freixas F; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain., Aguilar-Gurrieri C; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain., Toledo R; Infectious Diseases Department, Fight AIDS and Infectious Diseases Foundation (FLS), Germans Trias i Pujol Hospital, 08916 Badalona, Catalonia, Spain., Chamorro A; Infectious Diseases Department, Fight AIDS and Infectious Diseases Foundation (FLS), Germans Trias i Pujol Hospital, 08916 Badalona, Catalonia, Spain., Noguera-Julian M; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain., Mateu L; Infectious Diseases Department, Fight AIDS and Infectious Diseases Foundation (FLS), Germans Trias i Pujol Hospital, 08916 Badalona, Catalonia, Spain., Blanco I; Germans Trias i Pujol Hospital, 08916 Badalona, Catalonia, Spain., Grau E; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain., Massanella M; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain.; University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic, Catalonia, Spain.; CIBER Infectious Diseases (CIBERINFEC), Institute of Health Carlos III (ISCIII), Madrid, Spain., Carrillo J; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain., Clotet B; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain.; Infectious Diseases Department, Fight AIDS and Infectious Diseases Foundation (FLS), Germans Trias i Pujol Hospital, 08916 Badalona, Catalonia, Spain.; University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic, Catalonia, Spain., Trinité B; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain., Blanco J; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, UAB, 08916 Badalona, Catalonia, Spain.; University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic, Catalonia, Spain.; CIBER Infectious Diseases (CIBERINFEC), Institute of Health Carlos III (ISCIII), Madrid, Spain.
Publikováno v: IScience [iScience] 2023 Apr 21; Vol. 26 (4), pp. 106457. Date of Electronic Publication: 2023 Mar 20.
Zobrazit plný text záznamu
9
Akademický článek
An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses.
Autor: Tarrés-Freixas F; IrsiCaixa AIDS Research Institute, Can Ruti Campus, 08916, Badalona, Catalonia, Spain., Aguilar-Gurrieri C; IrsiCaixa AIDS Research Institute, Can Ruti Campus, 08916, Badalona, Catalonia, Spain., Rodríguez de la Concepción ML; IrsiCaixa AIDS Research Institute, Can Ruti Campus, 08916, Badalona, Catalonia, Spain., Urrea V; IrsiCaixa AIDS Research Institute, Can Ruti Campus, 08916, Badalona, Catalonia, Spain., Trinité B; IrsiCaixa AIDS Research Institute, Can Ruti Campus, 08916, Badalona, Catalonia, Spain., Ortiz R; IrsiCaixa AIDS Research Institute, Can Ruti Campus, 08916, Badalona, Catalonia, Spain., Pradenas E; IrsiCaixa AIDS Research Institute, Can Ruti Campus, 08916, Badalona, Catalonia, Spain., Blanco P; Comparative Medicine and Bioimage Centre of Catalonia (CMCiB), Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, 08916, Badalona, Catalonia, Spain., Marfil S; IrsiCaixa AIDS Research Institute, Can Ruti Campus, 08916, Badalona, Catalonia, Spain., Molinos-Albert LM; IrsiCaixa AIDS Research Institute, Can Ruti Campus, 08916, Badalona, Catalonia, Spain.; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain., Barajas A; IrsiCaixa AIDS Research Institute, Can Ruti Campus, 08916, Badalona, Catalonia, Spain., Pons-Grífols A; IrsiCaixa AIDS Research Institute, Can Ruti Campus, 08916, Badalona, Catalonia, Spain., Ávila-Nieto C; IrsiCaixa AIDS Research Institute, Can Ruti Campus, 08916, Badalona, Catalonia, Spain., Varela I; IrsiCaixa AIDS Research Institute, Can Ruti Campus, 08916, Badalona, Catalonia, Spain., Cervera L; Grup d'Enginyeria Cel•lular i Bioprocessos, Department of Chemical, Biological and Environmental Engineering, Escola d'Enginyeria, Universitat Autònoma de Barcelona, Campus de Bellaterra, 08913, Cerdanyola del Vallès, Catalonia, Spain., Gutiérrez-Granados S; Grup d'Enginyeria Cel•lular i Bioprocessos, Department of Chemical, Biological and Environmental Engineering, Escola d'Enginyeria, Universitat Autònoma de Barcelona, Campus de Bellaterra, 08913, Cerdanyola del Vallès, Catalonia, Spain., Segura MM; Grup d'Enginyeria Cel•lular i Bioprocessos, Department of Chemical, Biological and Environmental Engineering, Escola d'Enginyeria, Universitat Autònoma de Barcelona, Campus de Bellaterra, 08913, Cerdanyola del Vallès, Catalonia, Spain., Gòdia F; Grup d'Enginyeria Cel•lular i Bioprocessos, Department of Chemical, Biological and Environmental Engineering, Escola d'Enginyeria, Universitat Autònoma de Barcelona, Campus de Bellaterra, 08913, Cerdanyola del Vallès, Catalonia, Spain., Clotet B; IrsiCaixa AIDS Research Institute, Can Ruti Campus, 08916, Badalona, Catalonia, Spain.; University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic, Barcelona, Spain., Carrillo J; IrsiCaixa AIDS Research Institute, Can Ruti Campus, 08916, Badalona, Catalonia, Spain. jcarrillo@irsicaixa.es.; Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, Badalona, 08916, Barcelona, Spain. jcarrillo@irsicaixa.es.; CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. jcarrillo@irsicaixa.es., Blanco J; IrsiCaixa AIDS Research Institute, Can Ruti Campus, 08916, Badalona, Catalonia, Spain. jblanco@irsicaixa.es.; University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic, Barcelona, Spain. jblanco@irsicaixa.es.; Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, Badalona, 08916, Barcelona, Spain. jblanco@irsicaixa.es.; CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. jblanco@irsicaixa.es.
Publikováno v: NPJ vaccines [NPJ Vaccines] 2023 Apr 06; Vol. 8 (1), pp. 51. Date of Electronic Publication: 2023 Apr 06.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje